March 9th, 2017 – Shenzhen. A team from the international Synthetic Yeast Genome Project (Sc2.0 project) have announced the completion of the de novo redesign and synthesis of five more chromosomes of Saccharomyces cerevisiae; chromosomes II, V, VI, X and XII. The researchers also performed an in-depth, multi-dimensional analysis on the yeast strain, and confirmed that the phenotype of the synthetic yeast strain is consistent to that of the wild-type.
This author has yet to write their bio.Meanwhile lets just say that we are proud 501xnyhedeR501x-vb contributed a whooping 111 entries.
Entries by 501xnyhedeR501x-vb
The higher cost of NGS has prevented routine adoption of RNA sequencing, until now. BGI is proud to introduce Gene Expression Sequencing Services, with all the benefits from NGS data, but at a cost that is comparable to that of microarrays.
BGI will be attending the Royal College of Obstetricians and Gynaecologists 2017 Annual Conference in Cape Town, South Africa, 20-22 March. We’ll be at booth 52. Come and say hello and learn more about our wide range of genomics solutions across reproductive healthcare.
BGI, a leading global genomics organization headquartered in Shenzhen, announced it is expanding its international operations with the formation of a new division, BGI Groups USA, to be based in Seattle. BGI is engaged in scientific research, genomic sequencing, precision medicine, agriculture, bioinformatics and related technologies with a vision to use genomics to benefit humanity.
A BGI led team of researchers has sequenced the Ginkgo biloba genome and found it to be full of repeats, as well as gene clusters that may explain the tree’s remarkable resilience.
BGI is delighted to be attending the Festival of Genomics, London. Our Sequencing experts will be on-hand to answer all your questions on our NGS services. Please stop by our booth No. 61 to learn how we can help you generate the highest quality NGS data without the headaches.
BGI will join world leaders and host a session at the upcoming Precision Medicine World Conference, this coming January in Mountain View, California. The BGI executives will explore the possibilities of the information from a low-cost genome for patients and society. Jian Wang M.D., President and Co-Founder, BGI Healthcare in the Era of the […]
FREE Bioinformatic Analysis FROM $499 | 100x Coverage | 10G Data Guaranteed.
Do More With less – to celebrate the opening of the new academic year, BGI is introducing a unique opportunity get more bang for your buck with a limited-time exome promotion. Offer for a limited time only. Act Now!
BGI and five British Columbia-based biomedical and healthcare organizations have allied on personalized medicine. The Canadian partners include Providence Health Care, St. Paul’s Foundation, the Vancouver Prostate Centre, Genome BC, and Deloitte. Together, the organizations will create “health centers of excellence” in Shenzen, China, where BGI is based, and Vancouver, British Columbia.
Official opening of the China National GeneBank (CNGB) marks a new phase in Chinese-International genomics collaboration, providing scientists from across the world with access to one of the world’s most comprehensive and sophisticated biorepositories, with the goal of enabling breakthroughs in human health research and contributing to global biodiversity conservation efforts.
DK-2200 Copenhagen N,
Tel: (+45) 7026 0806
Cambridge, MA 02142 U.S.A.
Tel: (617) 500-2741
Chuo-ku, Kobe 650-0047
Tel: (+81)785 99 6108
Tai Po Industrial Zone,
Tel: (+852) 36103510
No.21 Hongan 3rd Street,
Yantian District, Shenzhen
Tel: (+86) 755 25273120